Milada Šírová

1.4k citations
45 papers · 1.2k indexed · h-index 21
Topics
Nanoparticle-Based Drug Delivery (26 papers)Nanoplatforms for cancer theranostics (11 papers)RNA Interference and Gene Delivery (8 papers)

In The Last Decade

Milada Šírová

44 papers receiving 1.2k citations

Peers

Milada Šírová
Comparison fields: 5 of 82
  • Biomaterials 808
  • Biomedical Engineering 495
  • Molecular Biology 396
  • Organic Chemistry 273
  • Polymers and Plastics 251
Replace Xianghui Xu with:
Xianghui Xu China
Abby M. Gonik United States
Aaron P. Griset United States
Robert Pola Czechia
Nate Larson United States
Nicholas L. Fletcher Australia
Anjan Nan United States
Dayi Pan China
Jesse B. Wolinsky United States
Yingjuan Lu United States
Milada Šírová relative to Xianghui Xu China Xianghui Xu's profile →
Citations per field
00.5×1.5×
Xianghui Xu · 1×
Citations per year

Countries citing papers authored by Milada Šírová

Since Specialization
Citations

This map shows the geographic impact of Milada Šírová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milada Šírová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milada Šírová more than expected).

Fields of papers citing papers by Milada Šírová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milada Šírová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milada Šírová. The network helps show where Milada Šírová may publish in the future.

Co-authorship network of co-authors of Milada Šírová

This figure shows the co-authorship network connecting the top 25 collaborators of Milada Šírová. A scholar is included among the top collaborators of Milada Šírová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milada Šírová. Milada Šírová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 8
4 6
5 29
6 39
7 9
8 24
9 45
10 35
11 9
12 30
13 7
14 27
15 78
16 54
17 15
18 2
19 6
20 1

About Milada Šírová

Milada Šírová is a scholar working on Biomaterials, Polymers and Plastics and Immunology, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (26 papers), Nanoplatforms for cancer theranostics (11 papers) and RNA Interference and Gene Delivery (8 papers). The work is most often cited by research in Biomaterials (808 citations), Polymers and Plastics (251 citations) and Biomedical Engineering (495 citations). Milada Šírová has collaborated with scholars based in Czechia, Belarus and United States. Frequent co-authors include Blanka Řı́hová, Tomáš Etrych, Karel Ulbrich, Petr Chytil, Tomáš Mrkvan, J. Strohalm, Vladimír Šubr, Čestmı́r Koňák, Marek Kovář and P Roßmann. Their work appears in journals such as Biomaterials, Cancer Research and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026